Literature DB >> 27688566

Risk Factors for Coronary Artery Disease in Indians.

D S Jaswal1, T K Saha2, N Aggarwal3.   

Abstract

BACKGROUND: A case control study was carried out to study the emerging risk factors for coronary artery disease in Indians.
METHODS: The diagnosis of coronary artery disease was based on correlation of clinical, biochemical, electrocardiography, echocardiography, treadmill testing and coronary arteriography findings. The study comprised 100 cases of coronary artery disease (acute coronary syndrome and chronic coronary artery disease) and 100 controls in two tertiary care service hospitals. The subjects were evaluated for total plasma homocysteine, insulin, C-reactive protein (CRP), lipoprotein fibrinogen and anti-chlamydial anti-bodies. RESULT: Male to female ratio was 10:1 in study group with similar predominance of males in controls. Mean age of the cases was 47 years (range 25-59 years) and that of controls was 43 years (range 23-56 years). 64% cases had acute coronary syndrome and 34% had chronic coronary artery disease. In the coronary artery disease population, 76% cases had hyperhomocyteinemia, 9% hyperinsulinaemia, 11% abnormal CRP values, 23% abnormal lipoprotein (a) levels, 40% IgG anti-chlamydial anti-bodies and only 11% had Ig M anti-chlamydial antibodies. In the control population, 72% had hyperhomocystinaemia and 6% hyperinsulinaemia while 23% and 9% controls had IgG and IgM anti chlamydial antibodies respectively. In control group 19% cases had abnormal lipoprotein(a) levels and only 2% had abnormal C reactive protein values. Significant correlation of CAD was seen with CRP values and Ig G anti-chlamydial antibodies. Both the study group and controls had higher homocysteine levels than that observed in some Indian and Western studies.
CONCLUSION: High C reactive protein levels and Ig G anti-chlamydial antibodies are associated with coronary artery disease in Indians. Insulin, lipoprotein A, fibrinogen, lgM anti-chlamydial antibodies and higher levels of total plasma homocysteine have no significant association with coronary artery disease.

Entities:  

Keywords:  Coronary artery disease; Emerging risk factors

Year:  2011        PMID: 27688566      PMCID: PMC5035247          DOI: 10.1016/S0377-1237(08)80008-1

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  20 in total

1.  ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions.

Authors:  P J Scanlon; D P Faxon; A M Audet; B Carabello; G J Dehmer; K A Eagle; R D Legako; D F Leon; J A Murray; S E Nissen; C J Pepine; R M Watson; J L Ritchie; R J Gibbons; M D Cheitlin; T J Gardner; A Garson; R O Russell; T J Ryan; S C Smith
Journal:  Circulation       Date:  1999-05-04       Impact factor: 29.690

2.  Lipoprotein (a) and lipid levels in young patients with myocardial infarction and their first-degree relatives.

Authors:  H S Isser; V K Puri; V S Narain; R K Saran; S K Dwivedi; S Singh
Journal:  Indian Heart J       Date:  2001 Jul-Aug

3.  Plasma fibrinogen--an independent risk factor for ischaemic heart disease.

Authors:  J Jose; D Selvakumar; R Selvakumar; A S Kanagasapabathy; L Jeyaseelan
Journal:  Indian Heart J       Date:  1998 Jan-Feb

4.  Insulin resistance, its consequences, and coronary heart disease. Must we choose one culprit?

Authors:  G M Reaven; Y D Chen
Journal:  Circulation       Date:  1996-05-15       Impact factor: 29.690

5.  Clustering of impaired glucose tolerance, hyperinsulinemia and dyslipidemia in young north Indian patients with coronary heart disease: a preliminary case-control study.

Authors:  A Misra; R B Reddy; K S Reddy; A Mohan; J S Bajaj
Journal:  Indian Heart J       Date:  1999 May-Jun

6.  Meta-analysis of coronary heart disease prevalence in India.

Authors:  R Gupta; V P Gupta
Journal:  Indian Heart J       Date:  1996 May-Jun

7.  Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial.

Authors:  G Montalescot; F Philippe; A Ankri; E Vicaut; E Bearez; J E Poulard; D Carrie; D Flammang; A Dutoit; A Carayon; C Jardel; M Chevrot; J P Bastard; F Bigonzi; D Thomas
Journal:  Circulation       Date:  1998-07-28       Impact factor: 29.690

8.  Association between incidence of lipoprotein(a) positivity and coronary heart disease.

Authors:  S Vashisht; H Wasir; L M Srivastava
Journal:  Indian Heart J       Date:  1992 Jul-Aug

9.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Authors:  S G Thompson; J Kienast; S D Pyke; F Haverkate; J C van de Loo
Journal:  N Engl J Med       Date:  1995-03-09       Impact factor: 91.245

10.  Plasma homocysteine concentration and coronary artery disease in Asian Indians.

Authors:  C Snehalatha; A Ramachandran; K Satyavani; S Sivasankari; I Sathyamurthy; V Viswanathan
Journal:  J Assoc Physicians India       Date:  2002-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.